Comparative analysis of neuroretinal alterations between patients with type 2 diabetes mellitus without evidence of diabetic retinopathy and a healthy control group
DOI:
https://doi.org/10.52379/mcs.v9.496Keywords:
Diabetes mellitus tipo 2, Retinopatía Diabética, Tomografía de coherencia óptica, capa de fibras nerviosas retinianas, complejo células ganglionares-plexiforme internaAbstract
Introduction: Type 2 Diabetes Mellitus (T2DM) causes insulin resistance and can lead to complications like Diabetic Retinopathy (DR), affecting vision. Optical Coherence Tomography (OCT) enables early detection. Objective: The study aimed to compare neuroretinal alterations between patients with Type 2 Diabetes Mellitus (T2DM) without evidence of Diabetic Retinopathy (DR) and a healthy control group. Methodology: The study included 220 eyes from 110 patients with T2DM without DR and 220 eyes from 110 healthy controls. Detailed interviews, comprehensive ophthalmologic evaluations, and Optical Coherence Tomography (OCT) were used to measure the thickness of the retinal nerve fiber layer (RNFL) and the ganglion cell-inner plexiform layer (GC-IPL). Results: Patients with T2DM showed significant thinning of the RNFL and GC-IPL compared to healthy controls. The average RNFL thickness in T2DM patients was 92.89 ± 7.87 µm, while in controls it was 97.28 ± 11.1 µm (p < 0.001). The GC-IPL thickness in T2DM patients was 80.03 ± 3.58 µm, compared to 81.09 ± 4.09 µm in controls (p < 0.001). Conclusion: There are significant differences in retinal layers between patients with T2DM without evidence of DR and healthy controls. These findings highlight the importance of early and continuous retinal monitoring in T2DM patients to prevent the progression of DR.
Downloads
References
1. Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci. Internet. 2020;21(17). http://dx.doi.org/10.3390/ijms21176275
2. Goyal R, Singhal M, Jialal I. Type 2 Diabetes. Internet. StatPearls Publishing; 2023. URL
3. GBD 2019 Blindness and Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):e144–60. http://dx.doi.org/10.1016/S2214-109X(20)30489-7
4. Bourne RRA, Jonas JB, Bron AM, Cicinelli MV, Das A, Flaxman SR, et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2018;102(5):575–85. http://dx.doi.org/10.1136/bjophthalmol-2017-311258
5. Aumann S, Donner S, Fischer J, Müller F. Optical Coherence Tomography (OCT): Principle and Technical Realization. Internet. Springer; 2019. URL
6. Ha A, Park KH. Optical Coherence Tomography for the Diagnosis and Monitoring of Glaucoma. Asia Pac J Ophthalmol (Phila). 2019;8(2):135–45. http://dx.doi.org/10.22608/APO.201902
7. Ulhaq ZS, Hasan YTN, Herawangsa S, Audris MA, Al Farizy MF, Aditya RD, et al. The retinal nerve fiber layer thickness is useful for the assessment of diabetic retinopathy severity. Diabetes Epidemiology and Management. 2022;7:100075. URL
8. Lang GE. Optical coherence tomography findings in diabetic retinopathy. Dev Ophthalmol. 2007;39:31–47. http://dx.doi.org/10.1159/000098498
9. Fahmy RM, Bhat RS, Al-Mutairi M, Aljaser FS, El-Ansary A. Correlation between glycemic control and peripapillary retinal nerve fiber layer thickness in Saudi type II diabetics. Clin Ophthalmol. 2018;12:419–25. http://dx.doi.org/10.2147/OPTH.S151564
10. Lopes de Faria JM, Russ H, Costa VP. Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy. Br J Ophthalmol. 2002;86(7):725–8. http://dx.doi.org/10.1136/bjo.86.7.725
11. Harwal N, Shashidhar S, Hithashree HR, Bypareddy R, Vishwanath BN. Comparative study to evaluate retinal changes using spectral-domain optical coherence tomography in diabetics without diabetic retinopathy. Indian J Ophthalmol. 2023;71(3):916–9. http://dx.doi.org/10.4103/ijo.IJO_1649_22
12. Chhablani J, Sharma A, Goud A, Peguda HK, Rao HL, Begum VU, et al. Neurodegeneration in Type 2 Diabetes: Evidence From Spectral-Domain Optical Coherence Tomography. Invest Ophthalmol Vis Sci. 2015;56(11):6333–8. http://dx.doi.org/10.1167/iovs.15-17334
13. Bhaskaran A, Babu M, Sudhakar NA, Kudlu KP, Shashidhara BC. Study of retinal nerve fiber layer thickness in diabetic patients using optical coherence tomography. Indian J Ophthalmol. 2023;71(3):920–6. http://dx.doi.org/10.4103/ijo.IJO_1918_22
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Rubén Darío Picco Pérez , Guillermo Raúl Vera Duarte, Sara Fernández , Verónica Elisa Castillo Benitez, Martín Fernando Arrúa Caballero, Luis González-Sanabria
This work is licensed under a Creative Commons Attribution 4.0 International License.
